Integration of Novel Emerging Technologies for
the Management of Type-2 Diabetes
Volume 1 - Issue 1
Gundu H R Rao*
-
Author Information
Open or Close
- Laboratory Medicine and Pathology, University of Minnesota, USA
*Corresponding author:
Gundu HR Rao, Laboratory Medicine and Pathology Director, Thrombosis Research, Lillehei Heart Institute,
University of Minnesota, USA
Received: May 03, 2018; Published: May 11, 2018
DOI: 10.32474/ADO.2018.01.000102
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
The incidence of twin epidemics, obesity and type-2 diabetes
are increasing rapidly worldwide in the past two decades [1-7]. By
azand large, clinicians manage diabetes by meticulous management
of blood glucose levels to meet the guidelines established by
professional societies and regulatory agencies (8, 9). The American
College of Physicians (ACP) published the most recent guideline in
April of this year (8).
Introduction|
Acknowledgement|
References|